GRFS Grifols
- 6.990
- -1.080-13.38%
- 6.990
- 0.0000.00%
About Grifols Company
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Company Profile
Company Executives
- Name
- Position
- Salary
- Jose Ignacio Abia Buenache
- Director and Chief Executive Officer
- --
- Alfredo Arroyo Guerra
- Chief Financial Officer
- --
- David Ian Bell
- General Counsel, Chief Corporate Development, Legal and Data Protection Officer
- --
- Daniel Fleta Coit
- Chief Industrial Services Officer
- --
- Miguel Louzan
- Chief Digital Information Officer
- --
- Raimon Grifols Roura
- Vice Chairman of the Board and Chief Corporate Officer
- --
- Maria Teresa Rione Llano
- Chief Communications Officer
- --
- Víctor Grifols Deu
- Director and Chief Operating Officer
- --
- Camille Alpi
- Chief Human Resources and Talent Officer
- --
- Dr. Jorg Schuttrumpf
- Chief Scientific Innovation Officer
- --
- Ignacio Ramal Subira
- Chief Internal Audit and Enterprise Risk Manager
- --
- Francisco Javier Guix Huguet
- Vice President, Healthcare Solutions
- --
- Laura Carratala Pena
- Vice President, Bio Supplies
- --
- Lluis Pons Gomez
- Senior Vice President, Strategy and COO Office
- --
- Jordi Balsells Valls
- President, Plasma Procurement
- --
- Dr. Roland Wandeler, PhD
- President, Biopharma Business Unit
- --
- Thomas H. Glanzmann
- Executive Chairman of the Board
- --
- Dr. Antonio Martinez Martinez
- President, Diagnostic Business Unit
- --
- Albert Grifols Coma-Cros
- Director
- --
- Tomas Daga Gelabert
- Director and Vice Secretary of the Board
- --
- Enriqueta Felip Font
- Independent Director
- --
- Carina Szpilka Lazaro
- Lead Independent Director
- --
- Inigo Sanchez-Asiain Mardones
- Independent Director
- --
- Susana Gonzalez Rodriguez
- Independent Director
- --
- Montserrat Munoz Abellana
- Independent Director
- --
- James Costos
- Independent Director
- --
- Laura de la Cruz Galan
- Vice Secretary
- --
- Nuria Martin Barnes
- Secretary
- --
Analysis
Price Target
No Data
No Data